Clinical Trials · NCT04689360
An Intermediate Size Expanded Access Protocol of Elamipretide
- Phase
- N/A
- Recruitment status
- Available
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 0
- Start date
- Not specified
- Locations
- See registry
- Primary endpoint
- Study in Mitochondrial Diseases